First National Bank & Trust CO Of Newtown Bristol Myers Squibb CO Transaction History

First National Bank & Trust CO Of Newtown

$477 Million
Q4 2024

A detailed history of First National Bank & Trust CO Of Newtown transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First National Bank & Trust CO Of Newtown holds 26,601 shares of BMY stock, worth $1.49 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

26,601

Previous 27,424 3.0%

Holding current value

$1.49 Million

Previous $1.42 Million 5.99%

% of portfolio

0.32%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$51.92 - $59.94 $42,730 - $49,330	-823 Reduced 3.0%	26,601 $1.5 Million
Q3 2024 Oct 31, 2024	SELL	$39.66 - $51.75 $11,263 - $14,697	-284 Reduced 1.02%	27,424 $1.42 Million
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $96,600 - $127,176	-2,400 Reduced 7.97%	27,708 $1.15 Million
Q1 2024 Apr 29, 2024	SELL	$47.98 - $54.4 $7,292 - $8,268	-152 Reduced 0.5%	30,108 $1.63 Million
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $28,845 - $34,420	-595 Reduced 1.93%	30,260 $1.55 Million
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $6,078 - $6,796	-105 Reduced 0.34%	30,855 $1.79 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $1,592 - $1,768	-25 Reduced 0.08%	30,960 $1.98 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $32,197 - $36,519	-490 Reduced 1.56%	30,985 $2.15 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $10,819 - $12,812	-158 Reduced 0.5%	31,475 $2.26 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $3 - $2,305	-30 Reduced 0.09%	31,633 $2.25 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $12,345 - $13,596	-170 Reduced 0.53%	31,663 $2.44 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $2,766 - $3,317	45 Added 0.14%	31,833 $2.32 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $13,139 - $15,317	-245 Reduced 0.76%	31,788 $1.98 Million
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $134,315 - $157,333	-2,270 Reduced 6.62%	32,033 $1.9 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $13,929 - $15,169	-225 Reduced 0.65%	34,303 $2.29 Million
Q1 2021 May 06, 2021	BUY	$59.34 - $66.74 $3,560 - $4,004	60 Added 0.17%	34,528 $2.18 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $78,179 - $88,592	-1,354 Reduced 3.78%	34,468 $2.14 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $17,516 - $19,410	305 Added 0.86%	35,822 $2.16 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $5,482 - $6,409	-100 Reduced 0.28%	35,517 $2.09 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $51,179 - $74,375	-1,103 Reduced 3.0%	35,617 $1.99 Million
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $15,993 - $20,861	-325 Reduced 0.88%	36,720 $2.36 Million
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $13,900 - $16,480	-325 Reduced 0.87%	37,045 $1.88 Million
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $33,018 - $36,511	-740 Reduced 1.94%	37,370 $1.69 Million
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $9,024 - $10,760	-200 Reduced 0.52%	38,110 $1.82 Million
Q4 2018 Jan 18, 2019	SELL	$48.76 - $63.23 $9,020 - $11,697	-185 Reduced 0.48%	38,310 $1.99 Million
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $75,941 - $85,656	-1,376 Reduced 3.45%	38,495 $2.39 Million
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $19,201 - $23,932	-380 Reduced 0.94%	39,871 $2.21 Million
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $20,972 - $24,143	-350 Reduced 0.86%	40,251 $2.55 Million
Q4 2017 Jan 17, 2018	SELL	$59.94 - $65.35 $61,738 - $67,310	-1,030 Reduced 2.47%	40,601 $2.49 Million
Q3 2017 Oct 25, 2017	BUY	$55.23 - $63.74 $2.3 Million - $2.65 Million	41,631	41,631 $2.65 Million

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank & Trust CO Of Newtown, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank & Trust CO Of Newtown with notifications on news.

Account

First National Bank & Trust CO Of Newtown Bristol Myers Squibb CO Transaction History